References
- Marks RM, Sachar EJ. Undertreatment of medical Inpatients with narcotic analgesics. Ann Intern Med 1973: 78(2): 173–81
- Parkes CM. Home or hospital? Terminal care as seen by surviving spouses. J R Coll Gen Pract 1978: 28(186): 19–30
- Bonica JJ. Cancer pain: importance of the problem. In: Bonica JJ. Ventafridda V, eds. Advances in pain research and therapy, vol 2. New York: Raven Press 1979: 1–12
- Twycross RG, Lack SA. Therapeutics in terminal cancer. London: Pitman 1984: 9
- Melzack R, Ofiesh JG, Mount BM. The Brompton mixture: effects on pain in cancer patients. Can Med Assoc J 1976: 115(2): 125–9
- Kaiko RF, Foley KM, Grabinaki PT. et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983: 13(2): 180–5
- Melzack R, Mount BM, Gordon JM. The Brompton mixture versus morphine solution given orally: effects on pain. Can Med Assoc J 1979: 120(4): 435–8
- Miller RR, Jick H. Clinical effects of meperidine In hospitalized medical patients. J Clin Pharmacol 1978: 18(4): 180–9
- Greenblatt DJ. Miller RR, eds. Drug effects in hospitalized patients: experiences of the Boston Collaborative Drug Surveillance Program, 1966–1975. New York: J Wiley. 1976: 133–64
- Twycross RG. Clinical experience with diamorphine in advanced malignant disease, Int J Clin Pharmacol 1974: 7(3): 184–98
- Twycross RG, Wald SJ. Long-term use of diamorphine in advanced cancer. In: Bonica JJ, Albe-Fessard DG, eds. Advances in pain research and therapy, vol 1. New York: Raven Press. 1976: 653–61